Takeda Pharmaceuticals U.S.A., Inc.

Home page	www.tpna.com
Business	Marketing
Key Products	Actos® (pioglitazone hydrochloride)
	ACTOplus met® (pioglitazone HCl and metformin HCl)
	Duetact® (pioglitazone HCl and glimepiride)
	Amitiza™ (lubiprostone)*
	Rozerem™ (ramelteon)
	Prevacid® (lansoprazole)
	DEXILANT™ (dexlansoprazole)
	ULORIC® (febuxostat)
	*Amitiza is a trademark of Sucampo Pharmaceuticals, Inc.
Address	One Takeda Parkway, Deerfield, IL 60015, USA
Telephone	+1- 224- 554- 6500
Contact	http://www.tpna.com/home/contact_us.aspx
Founded	1998

Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
In the United States, TPUSA currently markets oral diabetes, sleep, gastroenterology, cholesterol lowering treatments and chronic management of hyperuricemia in patients with gout, and through the Takeda Global Research & Development Center, Inc. the company has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions.

[*]The information presented at each company's website is governed by laws and regulations of that particular country, and therefore is intended for residents in that country only.